Hair loss
The field of hair and scalp health is rapidly emerging as one of the most dynamic areas in aesthetics
With an anticipated annual growth rate of 15.4% over the next five years, the demand for effective solutions to hair loss is intensifying.
Meanwhile, the global market for hair loss and growth treatments and products is forecasted to reach $5.66 billion by 2032, reflecting increasing consumer interest and spending. Hair loss is seen as a medical issue and a key aesthetic concern, driving demand for cutting-edge therapies that restore confidence and appearance.
The rising demand ties in with other trends, such as the capabilities of regenerative treatments in addressing hair loss as well as noted side effects of weight loss medications, including hair thinning.
Weight loss medications: The rising popularity of weight loss medications (like GLP-1 receptor agonists) has brought an unintended consequence – hair thinning. While there's no direct evidence that Ozempic causes hair loss, rapid weight loss from taking such drugs can lead to a condition called telogen effluvium, which can cause hair shedding. This is prompting patients to seek targeted treatments to combat this issue.
Female hair loss: Historically, the discussion around hair loss primarily focused on men; however, female hair loss is now gaining critical attention. With NHS statistics indicating that eight million women in the UK experience varying degrees of hair loss, there is a growing need for tailored solutions. This is further amplified by:
Menopause and hormonal changes: Women experiencing menopause are particularly susceptible to hair thinning and loss, leading to an increasing emphasis on therapies that address hormonal-related scalp concerns
Social acceptance and awareness: As women become more vocal about hair loss challenges, the stigma surrounding female hair thinning is diminishing, enabling more proactive treatment approaches
Regenerative solutions: Another driver is the fact that the aesthetics market is increasingly embracing regenerative solutions with treatments like platelet-rich plasma (PRP) therapy, stem cells, exosomes and polynucleotides also designed to rejuvenate the scalp and promote hair growth. These technologies are seen as non-invasive, effective, and progressive alternatives to traditional hair transplant surgery.
Wellness and personalisation: A broader understanding of wellness is influencing the market as brands and practitioners promote a holistic approach to hair and scalp care. This includes personalised treatments that address underlying causes like stress, nutrition, and hormonal imbalances. Combined with advancements in AI diagnostics, patients can receive highly individualised solutions that optimise results.
Regenerative solutions: PRP, exosome-based treatments, and stem cell therapies will dominate the conversation as non-surgical interventions continue to grow
Female hair loss: With menopause taking centre stage in the health and aesthetics market, expect an influx of innovations catering to women’s unique needs
Tech-driven solutions: AI diagnostics and wearable devices for scalp monitoring will become integral to customised treatment plans
Regenerative solutions like PRP, exosomes, and stem cell therapies
Tech-driven approaches, including AI diagnostics and personalised treatment plans
